High-risk stays high-risk: Bruton tyrosine kinase inhibitors in B-cell malignancies.Othman Al-SawafHaematologica(2024)引用 0|浏览1暂无评分摘要Not available.更多查看译文AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要